Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2-Syria, 2017-2018

被引:22
|
作者
Mbaeyi, Chukwuma [1 ]
Wadood, Zubair Mufti [2 ]
Moran, Thomas [2 ]
Ather, Fazal [3 ]
Stehling-Ariza, Tasha [4 ]
Nikulin, Joanna [2 ]
Al Safadi, Mohammad [2 ]
Iber, Jane [5 ]
Zomahoun, Laurel [1 ]
Abourshaid, Nidal [6 ]
Pang, Hong [5 ]
Collins, Nikki [5 ]
Asghar, Humayun [2 ]
Butt, Obaid ul Islam [2 ]
Burns, Cara C. [5 ]
Ehrhardt, Derek [1 ]
Sharaf, Magdi [2 ]
机构
[1] CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA 30333 USA
[2] WHO, Polio Eradicat Dept, Geneva, Switzerland
[3] United Nations Childrens Fund, Middle East & North Africa Off, Amman, Jordan
[4] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA
[5] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[6] United Nations Childrens Fund, Syria Country Off, Damascus, Syria
来源
关键词
PROGRESS; ERADICATION; WORLDWIDE;
D O I
10.15585/mmwr.mm6724a5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
What is already known about this topic? Oral poliovirus vaccine (OPV) contains live attenuated viruses, which rarely revert to neurovirulence. These vaccine-derived polioviruses (VDPVs) tend to emerge in populations with low OPV coverage and are capable of causing paralysis. What is added by this report? In 2017, an outbreak of circulating VDPV type 2 (cVDPV2) occurred in Syria, causing 74 cases. Implementation of three rounds of monovalent OPV type 2 campaigns coupled with intensified surveillance interrupted the outbreak. What are the implications for public health practice? The outbreak in Syria underscores the risk for emergence of vaccine-derived polioviruses in settings of low OPV coverage. High-quality surveillance and targeted vaccination using monovalent OPV type 2 are effective in controlling cVDPV2 outbreaks. © 2018, Department of Health and Human Services. All Rights reserved.
引用
收藏
页码:690 / 694
页数:5
相关论文
共 50 条
  • [31] Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola
    Vinjé, J
    Gregoricus, N
    Martin, J
    Gary, HE
    Cáceres, VM
    Venczel, L
    Macadam, A
    Dobbins, JG
    Burns, C
    Wait, D
    Ko, G
    Landaverde, M
    Kew, O
    Sobsey, MD
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07): : 1168 - 1175
  • [32] Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission - China, 2023
    Kang, Wei
    Fan, Chunxiang
    Song, Yifan
    Zhang, Zhaonan
    Wang, Xiaoqi
    Wang, Miao
    Ma, Jing
    Chen, Mulei
    Yang, Yuzhen
    Wen, Yi
    Cao, Lei
    Rodewald, Lance
    Wang, Fuzhen
    Yin, Zundong
    Wen, Ning
    Yang, Hong
    CHINA CDC WEEKLY, 2024, 6 (42):
  • [33] Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus
    Riquet, Franck B.
    Blanchard, Claire
    Jegouic, Sophie
    Balanant, Jean
    Guillot, Sophie
    Vibet, Marie-Anne
    Rakoto-Andrianarivelo, Mala
    Delpeyroux, Francis
    JOURNAL OF VIROLOGY, 2008, 82 (17) : 8927 - 8932
  • [34] Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020 q
    Macklin, Grace R.
    Goel, Ajay K.
    Mach, Ondrej
    Tallis, Graham
    Ahmed, Jamal A.
    O'Reilly, Kathleen M.
    Grassly, Nicholas C.
    Diop, Ousmane M.
    VACCINE, 2023, 41 : A19 - A24
  • [35] Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
    Yang, CF
    Naguib, T
    Yang, SJ
    Nasr, E
    Jorba, J
    Ahmed, N
    Campagnoli, R
    van der Avoort, H
    Shimizu, H
    Yoneyama, T
    Miyamura, T
    Pallansch, M
    Kew, O
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8366 - 8377
  • [36] Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
    Adu, Festus
    Iber, Jane
    Bukbuk, David
    Gumede, Nicksy
    Yang, Su-Ju
    Jorba, Jaume
    Campagnoli, Ray
    Sule, Waidi Folorunso
    Yang, Chen-Fu
    Burns, Cara
    Pallansch, Mark
    Harry, Tekena
    Kew, Olen
    VIRUS RESEARCH, 2007, 127 (01) : 17 - 25
  • [37] CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus - Africa and Philippines, September 2019-March 2020
    Meyer, Erika
    Sikka, Neha
    Durry, Elias
    Datta, Deblina
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (34): : 1182 - 1183
  • [38] Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda
    Tushabe, Phionah
    Bwogi, Josephine
    Eliku, James Peter
    Aine, Francis
    Birungi, Molly
    Gaizi, Joseph
    Nakabazzi, Lucy
    Kabaliisa, Theopista
    Turyahabwe, Irene
    Namuwulya, Prossy
    Nanteza, Mary Bridget
    Bukenya, Henry
    Kanyesigye, Christopher
    Katushabe, Edson
    Ampeire, Immaculate
    Kisakye, Annet
    Bakamutumaho, Barnabas
    Byabamazima, Charles R.
    ARCHIVES OF VIROLOGY, 2023, 168 (05)
  • [39] Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA
    Liu, Yanhan
    Ma, Tengfei
    Liu, Jianzhu
    Zhao, Xiaona
    Cheng, Ziqiang
    Guo, Huijun
    Xu, Ruixue
    Wang, Shujing
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (17): : 2096 - 2099
  • [40] Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda
    Phionah Tushabe
    Josephine Bwogi
    James Peter Eliku
    Francis Aine
    Molly Birungi
    Joseph Gaizi
    Lucy Nakabazzi
    Theopista Kabaliisa
    Irene Turyahabwe
    Prossy Namuwulya
    Mary Bridget Nanteza
    Henry Bukenya
    Christopher Kanyesigye
    Edson Katushabe
    Immaculate Ampeire
    Annet Kisakye
    Barnabas Bakamutumaho
    Charles R. Byabamazima
    Archives of Virology, 2023, 168